FASLG and lung cancer: In addition, FOXO3a negatively regulates the expression of miR-21, which targets the 3’UTR of the Fas ligand (FasL), a pro-apoptotic factor, and enhances doxorubicin-induced apoptosis in lung cancer cells [57].